The opioid antagonist naltrexone decreases seizure‐like activity in genetic and chemically induced epilepsy models
Sign Up to like & getrecommendations! Published in 2021 at "Epilepsia Open"
DOI: 10.1002/epi4.12512
Abstract: A significant number of epileptic patients fail to respond to available anticonvulsive medications. To find new anticonvulsive medications, we evaluated FDA‐approved drugs not known to be anticonvulsants. Using zebrafish larvae as an initial model system,… read more here.
Keywords: naltrexone decreases; antagonist naltrexone; epilepsy models; opioid antagonist ... See more keywords